Evidence map›Paper›PMID 35163606›Full record

ReviewInternational journal of molecular sciences2022

Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models.

Julie Bigarreau, Nathalie Rouach, Anselme L Perrier, Franck Mouthon, Mathieu Charvériat

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. hiPSC-Derived Cells as Models for Drug Discovery 2.0.International journal of molecular sciences · 2023
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Julie BigarreauTheranexus, 69008 Lyon, France.
Nathalie RouachNeuroglial Interactions in Cerebral Physiology and Pathologies, Center for Interdisciplinary Research in Biology, Collège de France, CNRS, INSERM, Labex Memolife, Université PSL, 75005 Paris, France.ORCID 0000-0002-5574-888X
Anselme L PerrierUniversité Paris-Saclay, Commissariat à l'Energie Atomique et aux Energies Alternatives, CNRS, Laboratoire des Maladies Neurodégénératives: Mécanismes, Thérapies, Imagerie, 92265 Fontenay-aux-Roses, France.
Franck MouthonTheranexus, 69008 Lyon, France.
Mathieu CharvériatTheranexus, 69008 Lyon, France.ORCID 0000-0003-2167-9705
Theranexus (France) · FRCentre National de la Recherche Scientifique · FR

Funding

Bpifrance NeuroLead
6 · The paper itself

Abstract

Generation of relevant and robust models for neurological disorders is of main importance for both target identification and drug discovery. The non-cell autonomous effects of glial cells on neurons have been described in a broad range of neurodegenerative and neurodevelopmental disorders, pointing to neuroglial interactions as novel alternative targets for therapeutics development. Interestingly, the recent breakthrough discovery of human induced pluripotent stem cells (hiPSCs) has opened a new road for studying neurological and neurodevelopmental disorders "in a dish". Here, we provide an overview of the generation and modeling of both neuronal and glial cells from human iPSCs and a brief synthesis of recent work investigating neuroglial interactions using hiPSCs in a pathophysiological context.

Indexed as

Cell DifferentiationNeurodegenerative DiseasesNeurodevelopmental DisordersHumansInduced Pluripotent Stem CellsNeurogliaastrocyteshuman pluripotent stem cellsmicroglianeuroglial interactionsneuronspathological modeling

Identifiers

PMID35163606
PMCPMC8836094
OpenAlexW4210333585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.